Cipla elevates Manoj Dimri as Group Business Head
Pharma industry veteran brings extensive experience in commercial strategy, business growth, and market leadership to his expanded role at Cipla
Pharma industry veteran brings extensive experience in commercial strategy, business growth, and market leadership to his expanded role at Cipla
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Call it a major breakthrough for diagnostic imaging
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
MRI is particularly valuable in pediatric care due to its non-invasive nature
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
India presents one of the world’s largest untapped opportunities for neurovascular screening
It is intended for contrast enhancement in MRI scans
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult patients
He holds a Master’s in Management from the National University of Singapore
Subscribe To Our Newsletter & Stay Updated